Search Results

The Distaflo Bypass Graft is intended for bypass or reconstruction of peripheral arterial blood vessels.

The Distaflo Bypass Graft is an expanded polytetrafluoroethylene (ePTFE) vascular graft with a cuffed distal end. The Distaflo Bypass Graft can be manufactured with or without Flex beading and with or without a carbon lining.

The provided text is a 510(k) Premarket Notification for the DISTAFLO™ Bypass Graft. It details the device, its intended use, and claims substantial equivalence to predicate devices based on performance data. However, it does not contain the specific information required to complete the table and answer all the questions about acceptance criteria and a study proving those criteria.

The document states: "Device testing was performed on the cuffed portion of the Distaflo Bypass Graft and compared to the results of testing performed on the IMPRA Carboflo Vascular Graft and the Venaflo Graft with Carbon." It further mentions the testing was conducted using methods recommended in "ANSVAAMI VP20-1994: Cardiovascular Implants - Vascular Prostheses and the 1993 FDA Draft Guidance: Guidance for the Preparation of Research and Marketing Applications for Vascular Graft Prostheses." It concludes that "The results of all testing indicated that the Distaflo Bypass Graft is suitable for bypass or reconstruction of peripheral arterial blood vessels and the anticipated conditions of use imposed on the device. The results demonstrated that the Distaflo Bypass Graft has been adequately designed to perform in a manner substantially equivalent to that of the predicate devices."

This is a high-level summary of performance data, but it does not provide specific acceptance criteria values, reported performance metrics, sample sizes, ground truth establishment methods, or details on expert involvement as requested. The document emphasizes substantial equivalence, meaning the device performs similarly to existing, legally marketed devices, rather than meeting specific, novel performance thresholds explicitly stated in this summary.

Therefore, I cannot fill out the table or answer most of the questions with the provided input.

Here's an attempt to answer what can be inferred or directly quoted:

1. A table of acceptance criteria and the reported device performance

2. Sample sizes used for the test set and the data provenance
The document does not explicitly state the sample sizes used for the device testing or the data provenance (e.g., country of origin, retrospective/prospective). It only mentions "Device testing was performed on the cuffed portion of the Distaflo Bypass Graft and compared to the results of testing performed on the IMPRA Carboflo Vascular Graft and the Venaflo Graft with Carbon."

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This information is not provided in the document. The testing appears to be based on engineering and material performance standards rather than clinical expert consensus for a ground truth.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not provided in the document.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This is not applicable as the device is a vascular graft, not an AI-assisted diagnostic tool involving human readers.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
This is not applicable as the device is a vascular graft, not an algorithm. The "standalone" performance here refers to the device's physical and mechanical performance.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The "ground truth" for this device appears to be defined by regulatory standards (ANSVAAMI VP20-1994, 1993 FDA Draft Guidance) and the performance characteristics of its predicate devices, rather than clinical outcomes or expert consensus in the diagnostic sense. The suitability is based on physical and mechanical testing.

8. The sample size for the training set
This is not applicable as this is a physical medical device, not an AI/machine learning model that requires a training set.

9. How the ground truth for the training set was established
This is not applicable for the reasons stated above.

Ask a specific question about this device

The Distaflo Bypass Graft is intended for bypass or reconstruction of peripheral arterial blood vessels.
Distaflo™ Bypass Grafts are intended for bypass or reconstruction of peripheral arterial blood vessels.

The Distaflo Bypass Graft is an expanded polytetrafluoroethylene (ePTFE) vascular graft with a cuffed distal end. The Distaflo Bypass Graft can be manufactured with or without Flex beading and with or without a carbon lining.

Here's a breakdown of the acceptance criteria and study findings for the IMPRA Distaflo™ Bypass Graft, based on the provided document:

Acceptance Criteria and Device Performance

The document does not explicitly present a table of acceptance criteria with numerical targets. Instead, it states that the testing aimed to demonstrate "substantial equivalence" to predicate devices. The "Performance Data" section indicates:

1. Table of Acceptance Criteria and Reported Device Performance:

2. Sample Size Used for the Test Set and Data Provenance:

• Sample Size: The document does not specify the exact sample size for the "test set" (i.e., the number of Distaflo Bypass Grafts or their components tested). It mentions "Device testing was performed on the cuffed portion of the Distaflo Bypass Graft."
• Data Provenance: The document does not provide information on the country of origin of the data or whether the study was retrospective or prospective. Given the nature of medical device testing for regulatory approval in the US (FDA 510(k)), it is generally assumed that the testing was conducted in a controlled lab environment by the manufacturer.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications:

This information is not applicable and not provided in the document. The "ground truth" for this type of device (vascular graft) is established through engineering and biocompatibility testing against predefined standards and performance characteristics, rather than expert consensus on diagnostic images or clinical outcomes in humans at this stage of approval.

4. Adjudication Method for the Test Set:

Not applicable. As described above, the evaluation relies on direct physical and mechanical testing against recognized standards and comparison to predicate devices, not on expert adjudication of observations.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done:

No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic imaging devices where human readers interpret results, and an AI algorithm might assist them. The Distaflo Bypass Graft is a physical implantable device, and its evaluation does not involve human readers interpreting AI output.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:

Not applicable. The device is not an algorithm. Its "performance" is inherently standalone, as it's a physical product assessed directly through testing, not an AI model.

7. The Type of Ground Truth Used:

The "ground truth" for the Distaflo Bypass Graft's performance is based on:

• Engineering and Material Standards: Compliance with methods recommended in ANSI/AAMI VP20-1994: Cardiovascular Implants - Vascular Prostheses and the 1993 FDA Draft Guidance: Guidance for the Preparation of Research and Marketing Applications for Vascular Graft Prostheses.
• Predicate Device Performance: Direct comparison of test results to the established performance of legally marketed predicate devices (IMPRA Carboflo Vascular Graft and Venaflo Graft with Carbon).
• Design and Manufacturing Equivalence: Verification that the device uses the same materials, processes, and a design concept (Miller Vein Cuff) found in established devices.

8. The Sample Size for the Training Set:

Not applicable. The Distaflo Bypass Graft is a manufactured medical device, not an AI model requiring a training set of data.

9. How the Ground Truth for the Training Set Was Established:

Not applicable, as there is no training set for this type of device.

Ask a specific question about this device